Stool antigen test: A stool sample is examined for substances associated with the bacterium. This can also help identify active infection and confirm eradication after treatment.
Endoscopy with biopsy: A clinician passes a thin, flexible instrument through the mouth to examine the upper digestive tract. Small tissue samples may be collected from the stomach for laboratory testing. Endoscopy may be recommended when symptoms, risk factors, or other findings warrant a closer examination.
Blood antibody tests: These detect antibodies to H. pylori. However, antibodies can remain present after an infection has cleared, so blood testing may not reliably distinguish current infection from past exposure.
The most appropriate test depends on a person's symptoms, medical history, medications, and the reason for testing.
Certain medications, including antibiotics, bismuth-containing products, and acid-suppressing drugs, can affect the accuracy of some tests. Patients should follow the testing instructions provided by their healthcare professional rather than stopping medication on their own.
6. Can Treating H. pylori Lower Stomach Cancer Risk?
Evidence indicates that eliminating H. pylori can reduce the risk of developing gastric cancer in some populations.
The US National Cancer Institute summarizes randomized studies and long-term follow-up research suggesting that eradication treatment can lower gastric cancer incidence, particularly in populations with relatively high baseline risk. <Cite refs={["turn985069search3","turn985069search7"]}/>
Treatment usually involves a combination of medicines, often including multiple antibiotics and an acid-suppressing drug. The exact regimen depends on local antibiotic resistance patterns, previous antibiotic exposure, allergies, and other clinical considerations.
People should not attempt to treat H. pylori using leftover antibiotics or a self-selected medication combination. Incomplete or inappropriate treatment can fail to eradicate the infection and contribute to antibiotic resistance.
After treatment, a follow-up test is often recommended to confirm that the bacterium has been eliminated. The timing and type of test should be determined by the treating clinician.
Eradicating H. pylori does not guarantee that stomach cancer will never develop. Risk may remain, especially if precancerous changes have already occurred. Nevertheless, appropriate diagnosis and treatment can be an important preventive measure for people who are infected.
Whether an asymptomatic person should be tested depends on individual risk, local guidelines, and clinical judgment. Blood type alone is not enough to determine the need for testing.
7. Does Everyone With Blood Group A Need Screening?
No. Having blood group A alone does not mean that someone needs special stomach cancer screening.
Screening recommendations vary between countries because the frequency of gastric cancer, available medical resources, and evidence supporting screening programs differ.
In regions where stomach cancer is relatively common, some health systems use organized screening strategies for defined age groups or higher-risk populations. In other settings, routine screening of every asymptomatic adult is not generally recommended.
Doctors may consider additional evaluation for people with factors such as a strong family history of stomach cancer, certain inherited cancer syndromes, known precancerous stomach changes, or a history that places them at elevated risk.
Persistent symptoms may also warrant diagnostic assessment. This is different from screening, which is performed in people who do not have symptoms to look for disease before it becomes apparent.
Blood type may be an interesting research variable, but it is not currently a substitute for established risk assessment.
If someone is worried about their risk, a useful conversation with a healthcare professional would focus on family history, previous stomach conditions, possible H. pylori infection, age, smoking, diet, and any ongoing digestive symptoms.
8. Symptoms That Deserve Medical Attention
Stomach cancer can cause symptoms that overlap with common digestive problems. Indigestion, bloating, nausea, or abdominal discomfort are frequent in the general population and are often caused by conditions other than cancer.
Nevertheless, symptoms that persist, worsen, or appear alongside other warning signs should not be ignored.
Possible warning signs include:
-
Persistent discomfort or pain in the upper abdomen.
-
Feeling full after eating only a small amount.
-
Reduced appetite that continues over time.
-
Unexplained weight loss.
-
Ongoing nausea or vomiting.
-
Difficulty swallowing.
-
Persistent fatigue that may be related to anemia.
-
Black, tarry stools or evidence of gastrointestinal bleeding.
None of these symptoms proves that a person has cancer. Ulcers, reflux, medication effects, and other gastrointestinal disorders can produce similar symptoms.
However, a healthcare professional can determine whether examination, laboratory tests, H. pylori testing, endoscopy, or another investigation is appropriate.
Vomiting blood, passing black tarry stools with weakness or dizziness, or experiencing severe or sudden abdominal pain may indicate a medical emergency and requires urgent assessment.
It is particularly important not to dismiss symptoms because someone has blood group O or to assume that someone with blood group A has cancer simply because they experience indigestion.
9. Family History Can Matter More Than Blood Type Alone
Inherited factors can contribute to stomach cancer risk, particularly when several close relatives have been affected or when cancer occurs at an unusually young age.
Most stomach cancers are not caused by a single inherited mutation. However, a minority are associated with hereditary conditions, including hereditary diffuse gastric cancer related to pathogenic variants in the CDH1 gene and certain other inherited cancer syndromes.